Human P450 metabolism of warfarin (Q41334623)

29 September 2017

title

Human P450 metabolism of warfarin (English)

1 reference

29 September 2017

Kaminsky LS

1

1 reference

29 September 2017

Zhang ZY

series ordinal

2

1 reference

29 September 2017

publication date

1 January 1997

1 reference

Pharmacology & Therapeutics

29 September 2017

published in

1 reference

29 September 2017

volume

73

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

67-74

1 reference

publication type of scholarly work

29 September 2017

review article

1 reference

Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Interphenotype differences in disposition and effect on gastrin levels of omeprazole—suitability of omeprazole as a probe for CYP2C19

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

The preferred solution conformation of warfarin at the active site of cytochrome P-450 based on the CD spectra in octanol/water model system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

The mechanism of the warfarin-rifampin drug interaction in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

The in vitro ketone reduction of warfarin and analogues. Substrate stereoselectivity, product stereoselectivity and species differences

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Effect of age and gender on the activity of human hepatic CYP3A

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Studies on 4-Hydroxycoumarins. V. The Condensation of α,β-Unsaturated Ketones with 4-Hydroxycoumarin1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4′-hydroxylation*

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Warfarin as a probe of cytochromes P-450 function

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Interaction between warfarin and propafenone in healthy volunteer subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Metabolic enantiomeric interactions: the inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular Modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Studies on a ketone reductase in human and rat liver and kidney soluble fraction using warfarin as a substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Azidowarfarin photoaffinity probes of purified rat liver cytochrome P4501A1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Interaction of chronic daily warfarin therapy and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

The stereoselective interaction of warfarin and metronidazole in man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Warfarin sodium derivative: (coumadin sodium); an intravenous hypoprothrombinemia-inducing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Enhancement of anticoagulant action by warfarin-benzbromarone interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Stereoselective interaction of omeprazole with warfarin in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

The warfarin-sulfinpyrazone interaction: stereochemical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Stereochemistry of cytochrome P-450 reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Mass spectral analysis in the identification of human metabolites of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

A study of the interaction of omeprazole and warfarin in anticoagulated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

Interactions of warfarin with drugs and food

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900140-4

7 January 2021

10.1016/S0163-7258(96)00140-4

Identifiers

DOI

1 reference

29 September 2017

1 reference